Education
About Us
Working with TipRanks
Follow Us
LENZ Therapeutics (LENZ)
NASDAQ:LENZ
Earnings Data
Report Date
Mar 25, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.95Last Year’s EPS
-0.46Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook for LENZ, highlighted by the successful early launch of VIZZ and significant financial backing. While there were minor issues with transient side effects and initial retail availability, the overall sentiment was bolstered by strong prescription metrics, high awareness among doctors, and strategic partnerships.Company Guidance
FDA Approval and Commercial Launch of VIZZ
LENZ achieved FDA approval for VIZZ ahead of schedule in July 2025 and successfully launched the product in the U.S. in early October 2025.
Strong Initial Prescription Metrics
Within the first month of launch, over 5,000 paid prescriptions were filled, and more than 2,500 doctors prescribed VIZZ, with 40% writing multiple prescriptions.
High Awareness Among Eye Care Professionals
A survey in mid-October 2025 showed 90% awareness of VIZZ among eye care professionals, indicating strong engagement and interest.
Strategic Financial Moves
LENZ raised over $123 million through direct placements, bringing their total cash position to approximately $324 million, ensuring a strong financial foundation for the VIZZ launch.
Partnership with Sarah Jessica Parker
LENZ announced Sarah Jessica Parker as the spokesperson for their upcoming direct-to-consumer campaign, which is set to launch in early 2026.
LENZ Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
LENZ Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | $28.05 | $21.47 | -23.46% |
Jul 30, 2025 | $31.67 | $30.76 | -2.87% |
May 07, 2025 | $25.34 | $25.87 | +2.09% |
Mar 19, 2025 | $25.52 | $26.30 | +3.06% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does LENZ Therapeutics (LENZ) report earnings?
LENZ Therapeutics (LENZ) is schdueled to report earning on Mar 25, 2026, After Close (Confirmed).
What is LENZ Therapeutics (LENZ) earnings time?
LENZ Therapeutics (LENZ) earnings time is at Mar 25, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LENZ EPS forecast?
LENZ EPS forecast for the fiscal quarter 2025 (Q4) is -0.95.